Megafine Pharma P Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Megafine Pharma is engaged in the production of APIs, and advanced intermediates, and offers contract manufacturing services.
One of their notable products is DARIFENACIN HYDROBROMIDE (NON STERILE DRUG SUBSTANCE), with a corresponding US DMF Number 26533.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 23, 2013, and payment made on March 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II